Adult growth hormone replacement has been approved for use in Australia for adults with poor quality of life. Approval requires documentation of biochemical evidence of growth hormone deficiency and poor quality of life that improves with growth hormone replacement.
Quality of life (QOL) is assessed using the Assessment of GH Deficiency in Adults (AGHDA) QOL questionnaire. Please find below the AGHDA-QOL questionnaire (which is licensed for use by ESA members) and instructions regarding its use, along with instructions for initiating and continuing growth hormone replacement.
Further information is available on the PBS website: http://www.pbs.gov.au/medicine/item/10426R-10431B-11495B-9586M
GH Replacement Application Forms and PBS criteria
For continuing adult growth hormone treatment, you can request the authority using the Online PBS Authorities system or by calling the PBS Complex Drugs Program enquire line on 1800 700 270.
Quality of Life assessments
Endocrine Society of Australia
145 Macquarie Street
Sydney. NSW. 2000
Email: ijohnson@endocrinesociety.org.au
The Endocrine Society of Australia acknowledges the Australian Aboriginal and Torres Strait Islander peoples as the first inhabitants of the nation and the traditional custodians of the lands where we live, learn and work. We pay our respects to their Elders past, present and emerging.
